E26.02 Glucocorticoid-remediable aldosteronism

Name of the Condition

• Glucocorticoid-remediable aldosteronism

Summary

Glucocorticoid-remediable aldosteronism is a rare, autosomal dominant form of primary hyperaldosteronism characterized by aldosterone overproduction that responds to glucocorticoid suppression. This condition leads to sodium retention, potassium loss, and elevated blood pressure, with potential electrolyte imbalances and cardiovascular complications.

Causes

The condition results from a genetic chimeric gene formed by unequal crossing over between the CYP11B1 and CYP11B2 genes. This gene causes aldosterone synthase to be abnormally regulated by adrenocorticotropic hormone (ACTH), leading to excessive aldosterone production in response to ACTH rather than the usual regulatory mechanisms.

Risk Factors

• Family history of glucocorticoid-remediable aldosteronism.
• Autosomal dominant inheritance pattern.
• Presence of the chimeric CYP11B1/B2 gene.

Symptoms

• High blood pressure (hypertension).
• Low potassium levels (hypokalemia).
• Muscle weakness or cramps.
• Headaches.
• Fatigue.

Diagnosis

Diagnosis involves measuring aldosterone and renin levels, with aldosterone suppression observed after glucocorticoid administration. Genetic testing for the chimeric CYP11B1/B2 gene confirms the diagnosis. Electrolyte panels and imaging studies may be used to rule out other causes of hyperaldosteronism.

Treatment Options

• Low-dose glucocorticoids to suppress aldosterone production.
• Mineralocorticoid receptor antagonists (e.g., spironolactone) if glucocorticoids are insufficient.
• Blood pressure management with antihypertensive medications.

Prognosis and Follow-Up

With appropriate treatment, prognosis is generally good, and blood pressure can be controlled. Regular monitoring of blood pressure, electrolyte levels, and renal function is recommended. Lifelong management is typically necessary due to the genetic nature of the condition.

Complications

• Severe hypertension.
• Cardiovascular complications (e.g., heart disease, stroke).
• Renal impairment from prolonged potassium loss.

Lifestyle & Prevention

• Adherence to prescribed medications.
• Regular blood pressure monitoring.
• Dietary modifications to manage sodium and potassium intake.
• Avoidance of medications that may exacerbate hypertension or electrolyte imbalances.

When to Seek Professional Help

Seek medical attention if experiencing severe hypertension, persistent muscle weakness, or symptoms of electrolyte imbalance (e.g., palpitations, fatigue). Prompt evaluation is important to prevent complications.

Tips for Medical Coders

Document the genetic confirmation of glucocorticoid-remediable aldosteronism when available, as this supports the diagnosis. Ensure documentation includes the response to glucocorticoid suppression testing, as this differentiates the condition from other forms of hyperaldosteronism. Code E26.02 is specific to this condition and should be used when the diagnosis is confirmed.